Vellanki Avanish

CIK 00018566821 companyNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001856682

Recent Transactions

19 trades

Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−152,150→ 0 total
Disposition from Tender
Rain Oncology Inc.
Common Stock, par value $0.001 per share
2024-01-26−2,550,910→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−14,115→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−266,500→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−133,250→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−30,150→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−304,485→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−31,832→ 0 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2023-08-09+266,500→ 266,500 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2023-08-09+133,250→ 133,250 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2023-02-15+318,600→ 318,600 total
Purchase
Rain Oncology Inc.
Common Stock
2022-06-01$2.29/sh+25,000→ 2,471,627 total
Gift
Rain Oncology Inc.
Common Stock
2022-04-14−59,618→ 79,283 total
Gift
Rain Oncology Inc.
Common Stock
2022-04-14+59,618→ 2,446,627 total
Exercise/Conversion
Rain Oncology Inc.
Common Stock
2022-03-11$4.00/sh+14,468→ 2,837,009 total
Exercise/Conversion
Rain Oncology Inc.
Stock Option (Right to Buy)
2022-03-11−14,468→ 31,832 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2022-02-02+182,300→ 182,300 total
Conversion
Rain Oncology Inc.
Series A Preferred Stock
2021-04-27−12,108→ 0 total
Conversion
Rain Oncology Inc.
Common Stock
2021-04-27+11,212→ 2,372,541 total

Companies

Rain Oncology Inc.
Director, President and CEO

Recent Filings

Address

C/O RAIN THERAPEUTICS INC. 8000 JARVIS AVENUE, SUITE 204

NEWARK, CA, 94560

View on SEC.gov